The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 11, 2023
Filed:
Dec. 28, 2017
Applicant:
Board of Regents, the University of Texas System, Austin, TX (US);
Inventors:
Cassian Yee, Houston, TX (US);
Ke Pan, Houston, TX (US);
Assignee:
BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM, Austin, TX (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/725 (2006.01); A61K 36/17 (2006.01); A61P 35/00 (2006.01); A61K 9/127 (2006.01); C07K 14/74 (2006.01); C07K 16/28 (2006.01); C12N 15/85 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 36/17 (2013.01); A61K 9/1271 (2013.01); A61P 35/00 (2018.01); C07K 14/7051 (2013.01); C07K 14/70539 (2013.01); C07K 16/2818 (2013.01); C12N 15/85 (2013.01); A61K 45/06 (2013.01); C07K 2319/02 (2013.01); C07K 2319/03 (2013.01);
Abstract
Provided herein are tumor-antigen VCX/Y specific peptides and engineered VCX/Y specific T cell receptors. Also provided herein are methods of generating VCX/Y-specific immune cells and their use for the treatment of cancer. In addition, the VCX/Y-specific peptides may be used as a vaccine.